Comparing two heart medicines for fast, irregular heartbeat
Part of Heart & circulation clinical trials.
This trial compares two common heart medicines (verapamil and metoprolol) to see which works better for people with a fast, irregular heartbeat called atrial fibrillation. If you come to the Emergency Department with a heart rate of 110 or more and are stable, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have atrial fibrillation with a heart rate of 110 or more, confirmed by an ECG
- You are stable (blood pressure is 90 or higher, no shock, no fluid in the lungs)
- You are not already on a heart rate control medicine (like metoprolol or verapamil) in the last 24 hours
- You do not have other heart conditions like certain blockages or Wolff-Parkinson-White syndrome
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different medicines to slow a rapid heartbeat caused by atrial fibrillation or flutter. You will receive either an oral pill (bisoprolol) or intravenous (IV) medication (diltiazem) to see which works better and faster.
This trial tests whether a self-management approach using either verapamil or metoprolol can help control your atrial fibrillation symptoms. It includes a smartphone app to track your heart rhythm and guide treatment changes.
This trial tests whether a target heart rate (below 80 beats per minute) is better than a more lenient one for people with persistent or permanent atrial fibrillation. It aims to find the best way to control your heart rate and improve your quality of life.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
This trial is testing whether giving amiodarone (a heart-rhythm medicine) before an electrical cardioversion can help restore normal heart rhythm better in people with persistent atrial fibrillation. The goal is to see if the medicine makes the procedure more likely to succeed and reduces the chance of the irregular rhythm returning.
This trial uses a procedure called electrical cardioversion (a controlled shock to restore a normal heart rhythm) to see if treating atrial fibrillation or atrial flutter can improve symptoms in people with heart failure. The goal is to find out if fixing the irregular heartbeat helps you breathe better, have more energy, and feel better overall.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.